超过80%的晚期卵巢癌患者因复发需要接受二线化疗。
More than 80% of patients with advanced ovarian cancer need second-line chemotherapy for the recurrence.
阿瓦·斯丁与静脉注射5 -氟尿嘧啶为基础的化疗联合治疗，是早先被批准的用于治疗结肠或直肠的转移性的癌症患者的一线或二线用药。
Avastin, in combination with intravenous 5-fluorouracil-based chemotherapy, was previously approved for first - or second-line treatment of patients with metastatic cancer of the colon or rectum.
尤其是对复发病人仍有效，可做为复发卵巢癌的二线或三线化疗。
It can be used in the patients with recurrent ovarian cancer as a second or third line therapy.
本文对此药在非小细胞肺癌一线、二线、维持治疗和辅助放化疗方面最新的研究进展进行了回顾和展望。
The latest progresses of pemetrexed in first-line treatment, second-line treatment, maintenance treatment, and adjuvant chemotherapy of non-small cell lung cancer are reviewed in the article.
本文对此药在非小细胞肺癌一线、二线、维持治疗和辅助放化疗方面最新的研究进展进行了回顾和展望。
The latest progresses of pemetrexed in first-line treatment, second-line treatment, maintenance treatment, and adjuvant chemotherapy of non-small cell lung cancer are reviewed in the article.
应用推荐